Edition:
United States

AB Science SA (ABS.PA)

ABS.PA on Paris Stock Exchange

14.86EUR
10:45am EST
Change (% chg)

€-0.17 (-1.13%)
Prev Close
€15.03
Open
€15.04
Day's High
€15.25
Day's Low
€14.74
Volume
102,631
Avg. Vol
122,893
52-wk High
€19.90
52-wk Low
€8.62

Select another date:

Fri, Jan 13 2017

BRIEF-AB Science issues 520,091 new shares

* Issues 520,091 new shares at a unit price of 14.62 euros ($15.54)/share Source text for Eikon: Further company coverage: ($1 = 0.9411 euros) (Gdynia Newsroom)

BRIEF-AB Science announces publication of pivotal phase 3 study masitinib results

* In pivotal phase 3 study masitinib administered at 6 mg/kg/day was significantly superior to placebo

BRIEF-Ab Science announces update on masitinib

* Announces the filing of masitinib in the treatment of amyotrophic lateral sclerosis (ALS) to the European medicines agency

BRIEF-AB Science H1 net loss widens to 14.8 million euros

* H1 net loss of 14.8 million euros versus loss of 13.0 million euros ($14.49 million) year ago

BRIEF-AB Science: Masitinib receives orphan drug designation in EU for ALS

* Announces that Masitinib receives from European Medicines Agency (EMA) orphan drug designation in the European Union for Amyotrophic Lateral Sclerosis (ALS) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: